세계의 척추 생물제제 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Spine Biologics Market - Scope of Report

TMR's report on the global Spine Biologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Spine Biologics Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Spine Biologics Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Spine Biologics Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Spine Biologics Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Spine Biologics Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Spine Biologics Market.

The report delves into the competitive landscape of the global Spine Biologics Market. Key players operating in the global Spine Biologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Spine Biologics Market profiled in this report.

Key Questions Answered in Global Spine Biologics Market Report:

• What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
• What are the opportunities in the global Spine Biologics Market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Spine Biologics Market - Research Objectives and Research Approach

The comprehensive report on the global Spine Biologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Spine Biologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Spine Biologics.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Spine Biologics Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Spine Biologics Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)
• 4.5. Porter's Five Forces Analysis

5. Key Insights

• 5.1. Technological Advancements
• 5.2. Reimbursement Scenario by Region/Globally
• 5.3. Regulatory Scenario by Region/Globally
• 5.4. Pipeline Analysis
• 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Spine Biologics Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Bone Allografts
  • 6.3.2. Bone Graft Substitute
  • 6.3.3. Platelet Rich Plasma
  • 6.3.4. Bone Marrow Aspirate Therapy
  • 6.3.5. Demineralized Bone Matrix (DBM)
  • 6.3.6. Others
• 6.4. Market Attractiveness Analysis, by Product

7. Global Spine Biologics Market Analysis and Forecast, by Surgery Type

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Surgery Type, 2017-2031
  • 7.3.1. Minimally Invasive Surgery
  • 7.3.2. Open Surgery
• 7.4. Market Attractiveness Analysis, by Surgery Type

8. Global Spine Biologics Market Analysis and Forecast, by Application

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Application, 2017-2031
  • 8.3.1. Spinal Fusion
  • 8.3.2. Spinal Non-union & Fracture Repair
  • 8.3.3. Degenerative Disc Disease Treatment
  • 8.3.4. Other Applications
• 8.4. Market Attractiveness Analysis, by Application

9. Global Spine Biologics Market Analysis and Forecast, by End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by End-user, 2017-2031
  • 9.3.1. Hospitals
  • 9.3.2. Spinal Surgery Centers
  • 9.3.3. Others
• 9.4. Market Attractiveness Analysis, by End-user

10. Global Spine Biologics Market Analysis and Forecast, by Region

• 10.1. Key Findings
• 10.2. Market Value Forecast, by Region, 2017-2031
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness Analysis, by Region

11. North America Spine Biologics Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2017-2031
  • 11.2.1. Bone Allografts
  • 11.2.2. Bone Graft Substitute
  • 11.2.3. Platelet Rich Plasma
  • 11.2.4. Bone Marrow Aspirate Therapy
  • 11.2.5. Demineralized Bone Matrix (DBM)
  • 11.2.6. Others
• 11.3. Market Value Forecast, by Surgery Type, 2017-2031
  • 11.3.1. Minimally Invasive Surgery
  • 11.3.2. Open Surgery
• 11.4. Market Value Forecast, by Application, 2017-2031
  • 11.4.1. Spinal Fusion
  • 11.4.2. Spinal Non-union & Fracture Repair
  • 11.4.3. Degenerative Disc Disease Treatment
  • 11.4.4. Other Applications
• 11.5. Market Value Forecast, by End-user, 2017-2031
  • 11.5.1. Hospitals
  • 11.5.2. Spinal Surgery Centers
  • 11.5.3. Others
• 11.6. Market Value Forecast, by Country, 2017-2031
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product
  • 11.7.2. By Surgery Type
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Spine Biologics Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Bone Allografts
  • 12.2.2. Bone Graft Substitute
  • 12.2.3. Platelet Rich Plasma
  • 12.2.4. Bone Marrow Aspirate Therapy
  • 12.2.5. Demineralized Bone Matrix (DBM)
  • 12.2.6. Others
• 12.3. Market Value Forecast, by Surgery Type, 2017-2031
  • 12.3.1. Minimally Invasive Surgery
  • 12.3.2. Open Surgery
• 12.4. Market Value Forecast, by Application, 2017-2031
  • 12.4.1. Spinal Fusion
  • 12.4.2. Spinal Non-union & Fracture Repair
  • 12.4.3. Degenerative Disc Disease Treatment
  • 12.4.4. Other Applications
• 12.5. Market Value Forecast, by End-user, 2017-2031
  • 12.5.1. Hospitals
  • 12.5.2. Spinal Surgery Centers
  • 12.5.3. Others
• 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product
  • 12.7.2. By Surgery Type
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country/Sub-region

13. Asia Pacific Spine Biologics Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2017-2031
  • 13.2.1. Bone Allografts
  • 13.2.2. Bone Graft Substitute
  • 13.2.3. Platelet Rich Plasma
  • 13.2.4. Bone Marrow Aspirate Therapy
  • 13.2.5. Demineralized Bone Matrix (DBM)
  • 13.2.6. Others
• 13.3. Market Value Forecast, by Surgery Type, 2017-2031
  • 13.3.1. Minimally Invasive Surgery
  • 13.3.2. Open Surgery
• 13.4. Market Value Forecast, by Application, 2017-2031
  • 13.4.1. Spinal Fusion
  • 13.4.2. Spinal Non-union & Fracture Repair
  • 13.4.3. Degenerative Disc Disease Treatment
  • 13.4.4. Other Applications
• 13.5. Market Value Forecast, by End-user, 2017-2031
  • 13.5.1. Hospitals
  • 13.5.2. Spinal Surgery Centers
  • 13.5.3. Others
• 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product
  • 13.7.2. By Surgery Type
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country/Sub-region

14. Latin America Spine Biologics Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product, 2017-2031
  • 14.2.1. Bone Allografts
  • 14.2.2. Bone Graft Substitute
  • 14.2.3. Platelet Rich Plasma
  • 14.2.4. Bone Marrow Aspirate Therapy
  • 14.2.5. Demineralized Bone Matrix (DBM)
  • 14.2.6. Others
• 14.3. Market Value Forecast, by Surgery Type, 2017-2031
  • 14.3.1. Minimally Invasive Surgery
  • 14.3.2. Open Surgery
• 14.4. Market Value Forecast, by Application, 2017-2031
  • 14.4.1. Spinal Fusion
  • 14.4.2. Spinal Non-union & Fracture Repair
  • 14.4.3. Degenerative Disc Disease Treatment
  • 14.4.4. Other Applications
• 14.5. Market Value Forecast, by End-user, 2017-2031
  • 14.5.1. Hospitals
  • 14.5.2. Spinal Surgery Centers
  • 14.5.3. Others
• 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product
  • 14.7.2. By Surgery Type
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country/Sub-region

15. Middle East & Africa Spine Biologics Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Product, 2017-2031
  • 15.2.1. Bone Allografts
  • 15.2.2. Bone Graft Substitute
  • 15.2.3. Platelet Rich Plasma
  • 15.2.4. Bone Marrow Aspirate Therapy
  • 15.2.5. Demineralized Bone Matrix (DBM)
  • 15.2.6. Others
• 15.3. Market Value Forecast, by Surgery Type, 2017-2031
  • 15.3.1. Minimally Invasive Surgery
  • 15.3.2. Open Surgery
• 15.4. Market Value Forecast, by Application, 2017-2031
  • 15.4.1. Spinal Fusion
  • 15.4.2. Spinal Non-union & Fracture Repair
  • 15.4.3. Degenerative Disc Disease Treatment
  • 15.4.4. Other Applications
• 15.5. Market Value Forecast, by End-user, 2017-2031
  • 15.5.1. Hospitals
  • 15.5.2. Spinal Surgery Centers
  • 15.5.3. Others
• 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product
  • 15.7.2. By Surgery Type
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country/Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (by tier and size of companies)
• 16.2. Market Share Analysis, by Company, 2022
• 16.3. Company Profiles
  • 16.3.1. Johnson And Johnson (Depuy Synthes)
    • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.1.2. Product Portfolio
    • 16.3.1.3. Financial Overview
    • 16.3.1.4. SWOT Analysis
    • 16.3.1.5. Strategic Overview
  • 16.3.2. Orthofix Medical Inc.
    • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.2.2. Product Portfolio
    • 16.3.2.3. Financial Overview
    • 16.3.2.4. SWOT Analysis
    • 16.3.2.5. Strategic Overview
  • 16.3.3. Stryker Corporation
    • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.3.2. Product Portfolio
    • 16.3.3.3. Financial Overview
    • 16.3.3.4. SWOT Analysis
    • 16.3.3.5. Strategic Overview
  • 16.3.4. Zimmer Biomet
    • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.4.2. Product Portfolio
    • 16.3.4.3. Financial Overview
    • 16.3.4.4. SWOT Analysis
    • 16.3.4.5. Strategic Overview
  • 16.3.5. Arthrex, Inc.
    • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.5.2. Product Portfolio
    • 16.3.5.3. Financial Overview
    • 16.3.5.4. SWOT Analysis
    • 16.3.5.5. Strategic Overview
  • 16.3.6. Exactech, Inc.
    • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.6.2. Product Portfolio
    • 16.3.6.3. Financial Overview
    • 16.3.6.4. SWOT Analysis
    • 16.3.6.5. Strategic Overview
  • 16.3.7. Spine Wave, Inc.
    • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.7.2. Product Portfolio
    • 16.3.7.3. Financial Overview
    • 16.3.7.4. SWOT Analysis
    • 16.3.7.5. Strategic Overview
  • 16.3.8. Medtronic plc
    • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.8.2. Product Portfolio
    • 16.3.8.3. Financial Overview
    • 16.3.8.4. SWOT Analysis
    • 16.3.8.5. Strategic Overview
  • 16.3.9. NuVasive, Inc.
    • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.9.2. Product Portfolio
    • 16.3.9.3. Financial Overview
    • 16.3.9.4. SWOT Analysis
    • 16.3.9.5. Strategic Overview